Company Description

iRepertoire pioneered the commercialization of NGS based immune repertoire sequencing of T and B Cells, the biological frontline defense from disease and infections. iRepertoire’s services are uniquely positioned to capture all seven TCR and BCR chains for a comprehensive picture of the immune system status. This allows for detailed treatment response tracking and improved patient outcomes.